Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases.

Miglianico M, Eldering M, Slater H, Ferguson N, Ambrose P, Lees RS, Koolen KMJ, Pruzinova K, Jancarova M, Volf P, Koenraadt CJM, Duerr HP, Trevitt G, Yang B, Chatterjee AK, Wisler J, Sturm A, Bousema T, Sauerwein RW, Schultz PG, Tremblay MS, Dechering KJ.

Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6920-E6926. doi: 10.1073/pnas.1801338115. Epub 2018 Jul 2.

2.

Modelling mosquito infection at natural parasite densities identifies drugs targeting EF2, PI4K or ATP4 as key candidates for interrupting malaria transmission.

Dechering KJ, Duerr HP, Koolen KMJ, Gemert GV, Bousema T, Burrows J, Leroy D, Sauerwein RW.

Sci Rep. 2017 Dec 15;7(1):17680. doi: 10.1038/s41598-017-16671-0.

3.
4.

Relationship between Histological and Clinical Course of Psoriasis: A Pilot Investigation by Reflectance Confocal Microscopy during Goeckerman Treatment.

Archid R, Duerr HP, Patzelt A, Philipp S, Röwert-Huber HJ, Ulrich M, Meinke MC, Knorr F, Lademann J.

Skin Pharmacol Physiol. 2016;29(1):47-54. doi: 10.1159/000443211. Epub 2016 Feb 4.

5.

Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials.

Blagden M, Hafer J, Duerr H, Hopp M, Bosse B.

Neurogastroenterol Motil. 2014 Dec;26(12):1792-801. doi: 10.1111/nmo.12463. Epub 2014 Oct 23.

6.

Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.

Ahmedzai SH, Leppert W, Janecki M, Pakosz A, Lomax M, Duerr H, Hopp M.

Support Care Cancer. 2015 Mar;23(3):823-30. doi: 10.1007/s00520-014-2435-5. Epub 2014 Sep 14.

7.

Quantitative evaluation of benign and malignant vertebral fractures with diffusion-weighted MRI: what is the optimum combination of b values for ADC-based lesion differentiation with the single-shot turbo spin-echo sequence?

Geith T, Schmidt G, Biffar A, Dietrich O, Duerr HR, Reiser M, Baur-Melnyk A.

AJR Am J Roentgenol. 2014 Sep;203(3):582-8. doi: 10.2214/AJR.13.11632.

PMID:
25148160
8.

A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.

Schanzer JM, Wartha K, Croasdale R, Moser S, Künkele KP, Ries C, Scheuer W, Duerr H, Pompiati S, Pollman J, Stracke J, Lau W, Ries S, Brinkmann U, Klein C, Umana P.

J Biol Chem. 2014 Jul 4;289(27):18693-706. doi: 10.1074/jbc.M113.528109. Epub 2014 May 19.

9.

Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent.

Stauch A, Duerr HP, Picado A, Ostyn B, Sundar S, Rijal S, Boelaert M, Dujardin JC, Eichner M.

PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2810. doi: 10.1371/journal.pntd.0002810. eCollection 2014 Apr.

10.

Pigmented villo-nodular synovitis and giant-cell tumor of tendon sheaths: a binational retrospective study.

Bruns J, Ewerbeck V, Dominkus M, Windhager R, Hassenpflug J, Windhagen H, Hovy L, Loehr J, Krauspe R, Duerr HR.

Arch Orthop Trauma Surg. 2013 Aug;133(8):1047-53. doi: 10.1007/s00402-013-1770-1. Epub 2013 May 17.

PMID:
23681468
11.

Crystal structure of an anti-Ang2 CrossFab demonstrates complete structural and functional integrity of the variable domain.

Fenn S, Schiller CB, Griese JJ, Duerr H, Imhof-Jung S, Gassner C, Moelleken J, Regula JT, Schaefer W, Thomas M, Klein C, Hopfner KP, Kettenberger H.

PLoS One. 2013 Apr 17;8(4):e61953. doi: 10.1371/journal.pone.0061953. Print 2013.

12.

Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India.

Stauch A, Duerr HP, Dujardin JC, Vanaerschot M, Sundar S, Eichner M.

PLoS Negl Trop Dis. 2012;6(12):e1973. doi: 10.1371/journal.pntd.0001973. Epub 2012 Dec 20.

13.

Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control.

Stauch A, Sarkar RR, Picado A, Ostyn B, Sundar S, Rijal S, Boelaert M, Dujardin JC, Duerr HP.

PLoS Negl Trop Dis. 2011 Nov;5(11):e1405. doi: 10.1371/journal.pntd.0001405. Epub 2011 Nov 29.

14.

Primary effusion lymphoma (PEL) without effusion: a patient case report of a PEL solid variant.

Giessen C, Di Gioia D, Huber B, Seppi B, Graser A, Duerr HR, Mayr D, Kirchner T, Rosenwald A, Forstpointner R, Heinemann V, Bogner JR, Ostermann H.

J Clin Pathol. 2012 Feb;65(2):189-90. doi: 10.1136/jclinpath-2011-200279. Epub 2011 Oct 19. No abstract available.

PMID:
22011447
15.

Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.

Duerr HP, Raddatz G, Eichner M.

Int J Parasitol. 2011 Apr;41(5):581-9. doi: 10.1016/j.ijpara.2010.12.009. Epub 2011 Jan 19.

PMID:
21255577
16.

Diffusion and perfusion imaging of bone marrow.

Biffar A, Dietrich O, Sourbron S, Duerr HR, Reiser MF, Baur-Melnyk A.

Eur J Radiol. 2010 Dec;76(3):323-8. doi: 10.1016/j.ejrad.2010.03.011. Epub 2010 Apr 8. Review.

PMID:
20381277
17.

Relations between haemoglobin mass, cardiac dimensions and aerobic capacity in endurance trained cyclists.

Ahlgrim C, Pottgiesser T, Kron J, Duerr H, Baumstark M, Schumacher YO.

J Sports Med Phys Fitness. 2009 Dec;49(4):364-71.

PMID:
20087295
18.

Influenza--insights from mathematical modelling.

Mikolajczyk R, Krumkamp R, Bornemann R, Ahmad A, Schwehm M, Duerr HP.

Dtsch Arztebl Int. 2009 Nov;106(47):777-82. doi: 10.3238/arztebl.2009.0777. Epub 2009 Nov 20.

19.

Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.

Duerr HP, Eichner M.

Int J Parasitol. 2010 May;40(6):641-50. doi: 10.1016/j.ijpara.2009.10.016. Epub 2009 Nov 24.

PMID:
19941867
20.

Effects of interventions on the demand for hospital services in an influenza pandemic: a sensitivity analysis.

Vidondo B, Oberreich J, Brockmann SO, Duerr HP, Schwehm M, Eichner M.

Swiss Med Wkly. 2009 Sep 5;139(35-36):505-10. doi: smw-12737.

PMID:
19675954
21.

Fiducial-free real-time image-guided robotic radiosurgery for tumors of the sacrum/pelvis.

Muacevic A, Drexler C, Kufeld M, Romanelli P, Duerr HJ, Wowra B.

Radiother Oncol. 2009 Oct;93(1):37-44. doi: 10.1016/j.radonc.2009.05.023. Epub 2009 Jun 22.

PMID:
19552980
22.

Antiviral prophylaxis during pandemic influenza may increase drug resistance.

Eichner M, Schwehm M, Duerr HP, Witschi M, Koch D, Brockmann SO, Vidondo B.

BMC Infect Dis. 2009 Jan 20;9:4. doi: 10.1186/1471-2334-9-4.

23.

Radiofrequency ablation in the treatment of osteoid osteoma-5-year experience.

Hoffmann RT, Jakobs TF, Kubisch CH, Trumm CG, Weber C, Duerr HR, Helmberger TK, Reiser MF.

Eur J Radiol. 2010 Feb;73(2):374-9. doi: 10.1016/j.ejrad.2008.11.018. Epub 2009 Jan 13.

PMID:
19144485
24.

Modeling the effects of drug resistant influenza virus in a pandemic.

Brockmann SO, Schwehm M, Duerr HP, Witschi M, Koch D, Vidondo B, Eichner M.

Virol J. 2008 Oct 30;5:133. doi: 10.1186/1743-422X-5-133.

25.

Does resistance to filarial reinfections become leaky over time?

Duerr HP, Hoffmann WH, Eichner M.

Trends Parasitol. 2008 Aug;24(8):350-4. doi: 10.1016/j.pt.2008.04.005. Epub 2008 Jun 19.

PMID:
18571986
26.

Impact of public health interventions in controlling the spread of SARS: modelling of intervention scenarios.

Krumkamp R, Duerr HP, Reintjes R, Ahmad A, Kassen A, Eichner M.

Int J Hyg Environ Health. 2009 Jan;212(1):67-75. doi: 10.1016/j.ijheh.2008.01.004. Epub 2008 May 6.

PMID:
18462994
27.

Detection of osseous metastases of the spine: comparison of high resolution multi-detector-CT with MRI.

Buhmann Kirchhoff S, Becker C, Duerr HR, Reiser M, Baur-Melnyk A.

Eur J Radiol. 2009 Mar;69(3):567-73. doi: 10.1016/j.ejrad.2007.11.039. Epub 2008 Jan 11.

PMID:
18191356
28.

Diagnostic value of nodule palpation in onchocerciasis.

Duerr HP, Raddatz G, Eichner M.

Trans R Soc Trop Med Hyg. 2008 Feb;102(2):148-54. Epub 2007 Dec 21.

PMID:
18082234
29.

Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions.

Duerr HP, Brockmann SO, Piechotowski I, Schwehm M, Eichner M.

BMC Infect Dis. 2007 Jul 13;7:76.

30.

Blood transfusion and spread of variant Creutzfeldt-Jakob disease.

Dietz K, Raddatz G, Wallis J, Müller N, Zerr I, Duerr HP, Lefèvre H, Seifried E, Löwer J.

Emerg Infect Dis. 2007 Jan;13(1):89-96.

31.

The influenza pandemic preparedness planning tool InfluSim.

Eichner M, Schwehm M, Duerr HP, Brockmann SO.

BMC Infect Dis. 2007 Mar 13;7:17.

32.

The impact of contact structure on infectious disease control: influenza and antiviral agents.

Duerr HP, Schwehm M, Leary CC, De Vlas SJ, Eichner M.

Epidemiol Infect. 2007 Oct;135(7):1124-32. Epub 2007 Feb 9.

33.

High infection rates at low transmission potentials in West African onchocerciasis.

Duerr HP, Leary CC, Eichner M.

Int J Parasitol. 2006 Nov;36(13):1367-72. Epub 2006 Aug 31.

PMID:
16979644
34.

Determinants of the eradicability of filarial infections: a conceptual approach.

Duerr HP, Dietz K, Eichner M.

Trends Parasitol. 2005 Feb;21(2):88-96. Review.

PMID:
15664532
35.

Modeling senescence in hypotrichous ciliates.

Duerr HP, Eichner M, Ammermann D.

Protist. 2004 Mar;155(1):45-52.

PMID:
15144057
36.

The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis.

Duerr HP, Dietz K, Schulz-Key H, Büttner DW, Eichner M.

Int J Parasitol. 2004 Mar 29;34(4):463-73.

PMID:
15013736
37.

Impact of parental onchocerciasis and intensity of transmission on development and persistence of Onchocerca volvulus infection in offspring: an 18 year follow-up study.

Kirch AK, Duerr HP, Boatin B, Alley WS, Hoffmann WH, Schulz-Key H, Soboslay PT.

Parasitology. 2003 Oct;127(Pt 4):327-35.

PMID:
14636019
38.

Density-dependent parasite establishment suggests infection-associated immunosuppression as an important mechanism for parasite density regulation in onchocerciasis.

Duerr HP, Dietz K, Schulz-Key H, Büttner DW, Eichner M.

Trans R Soc Trop Med Hyg. 2003 Mar-Apr;97(2):242-50.

PMID:
14584385
39.

On the interpretation of age-intensity profiles and dispersion patterns in parasitological surveys.

Duerr HP, Dietz K, Eichner M.

Parasitology. 2003 Jan;126(Pt 1):87-101.

PMID:
12613767
40.

Acute osteoporotic and neoplastic vertebral compression fractures: fluid sign at MR imaging.

Baur A, Stäbler A, Arbogast S, Duerr HR, Bartl R, Reiser M.

Radiology. 2002 Dec;225(3):730-5.

PMID:
12461253
41.

Efficacy of povidone-iodine vaginal suppositories in the treatment of bacterial vaginosis.

Wewalka G, Stary A, Bosse B, Duerr HE, Reimer K.

Dermatology. 2002;204 Suppl 1:79-85.

PMID:
12011527
42.

A stochastic model for the aggregation of Onchocerca volvulus in nodules.

Duerr HP, Dietz K, Buttner DW, Schulz-Key H.

Parasitology. 2001 Aug;123(Pt 2):193-201.

PMID:
11510685
43.

Stochastic models for aggregation processes.

Duerr HP, Dietz K.

Math Biosci. 2000 Jun;165(2):135-45.

PMID:
10854615
44.

Castor oil decreases pain during extracorporeal shock wave application.

Maier M, Staupendahl D, Duerr HR, Refior HJ.

Arch Orthop Trauma Surg. 1999;119(7-8):423-7.

PMID:
10613232
45.

Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers.

Hinderling PH, Tendolkar A, Dee CM, Barr WH, Seiberling M, Duerr H.

J Clin Pharmacol. 1995 Jul;35(7):721-9.

PMID:
7560253
46.

[Phagocytosis of Amoeba by leukocytes (Microcinematography observations)].

GROSS F, KRADOLFER F, DUERR H.

Schweiz Z Pathol Bakteriol. 1959;22:607-8. German. No abstract available.

PMID:
13829625

Supplemental Content

Support Center